Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP912683.RAgdbVegFhXgzZ34WqNL43s8sy9_fJPQLOvGPhK27UJ1I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP912683.RAgdbVegFhXgzZ34WqNL43s8sy9_fJPQLOvGPhK27UJ1I130_assertion type Assertion NP912683.RAgdbVegFhXgzZ34WqNL43s8sy9_fJPQLOvGPhK27UJ1I130_head.
- NP912683.RAgdbVegFhXgzZ34WqNL43s8sy9_fJPQLOvGPhK27UJ1I130_assertion description "[Our findings warrant a further pre-clinical evaluation of an experimental anti-glioma therapy with TRAIL and Troglitazone, potentially in conjunction with a MAP kinase inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP912683.RAgdbVegFhXgzZ34WqNL43s8sy9_fJPQLOvGPhK27UJ1I130_provenance.
- NP912683.RAgdbVegFhXgzZ34WqNL43s8sy9_fJPQLOvGPhK27UJ1I130_assertion evidence source_evidence_literature NP912683.RAgdbVegFhXgzZ34WqNL43s8sy9_fJPQLOvGPhK27UJ1I130_provenance.
- NP912683.RAgdbVegFhXgzZ34WqNL43s8sy9_fJPQLOvGPhK27UJ1I130_assertion SIO_000772 19158480 NP912683.RAgdbVegFhXgzZ34WqNL43s8sy9_fJPQLOvGPhK27UJ1I130_provenance.
- NP912683.RAgdbVegFhXgzZ34WqNL43s8sy9_fJPQLOvGPhK27UJ1I130_assertion wasDerivedFrom befree-20140225 NP912683.RAgdbVegFhXgzZ34WqNL43s8sy9_fJPQLOvGPhK27UJ1I130_provenance.
- NP912683.RAgdbVegFhXgzZ34WqNL43s8sy9_fJPQLOvGPhK27UJ1I130_assertion wasGeneratedBy ECO_0000203 NP912683.RAgdbVegFhXgzZ34WqNL43s8sy9_fJPQLOvGPhK27UJ1I130_provenance.